According to Digirad, the Cardius X-Act is a rapid cardiac Single photon emission computed tomography (SPECT)/VCT imaging system that features a low-dose volume-computed tomography (VCT) attenuation correction system that significantly reduces artifacts in the images caused by overlying tissues increasing interpretive ease and accuracy.
The X-Act approach takes advantage of the full 24-inch wide detector array eliminating truncation and generating high-precision transmission maps improving the overall quality of SPECT studies, the company said.
The X-Act attenuation correction system offers high accuracy, fast acquisition, low dose (5uSv/study) and superb reliability. The system’s high-speed triple-head solid-state design combined with nSPEED software allows the combined cardiac SPECT emission and transmission acquisitions to be performed in as little as five minutes, the company added.
Todd Clyde, CEO of Digirad, said: “The X-Act system is an important step forward in our strategy to drive the evolution of nuclear cardiac imaging by introducing a series of advanced solid state cameras that are distinguished by their ability to increase diagnostic accuracy; make earlier detection of disease possible; or by providing new clinical information that raises sensitivity or specificity of nuclear cardiology procedures.”